BIK drives an aggressive breast cancer phenotype through sublethal apoptosis and predicts poor prognosis of ER-positive breast cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
BIK drives an aggressive breast cancer phenotype through sublethal apoptosis and predicts poor prognosis of ER-positive breast cancer
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 11, Issue 6, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-11
DOI
10.1038/s41419-020-2654-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A molecular signature for anastasis, recovery from the brink of apoptotic cell death
- (2017) Gongping Sun et al. JOURNAL OF CELL BIOLOGY
- Executioner caspases and CAD are essential for mutagenesis induced by TRAIL or vincristine
- (2017) Mark A Miles et al. Cell Death & Disease
- Bik reduces hyperplastic cells by increasing Bak and activating DAPk1 to juxtapose ER and mitochondria
- (2017) Yohannes A. Mebratu et al. Nature Communications
- Essential roles of Caspase-3 in facilitating Myc-induced genetic instability and carcinogenesis
- (2017) Ian M Cartwright et al. eLife
- Validation of suitable normalizers for miR expression patterns analysis covering tumour heterogeneity
- (2017) C. Morata-Tarifa et al. Scientific Reports
- Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer
- (2016) Le Zhang et al. CELL CYCLE
- The caspase-activated DNase: apoptosis and beyond
- (2016) Brian D. Larsen et al. FEBS Journal
- Ligand-induced growth and compaction of CD36 nanoclusters enriched in Fyn induces Fyn signaling
- (2016) John Maringa Githaka et al. JOURNAL OF CELL SCIENCE
- Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
- (2016) Andrew W. Roberts et al. NEW ENGLAND JOURNAL OF MEDICINE
- The pro-apoptotic paradox: the BH3-only protein Bcl-2 interacting killer (Bik) is prognostic for unfavorable outcomes in breast cancer
- (2016) Vrajesh Pandya et al. Oncotarget
- The BCL-2 protein family, BH3-mimetics and cancer therapy
- (2015) A R D Delbridge et al. CELL DEATH AND DIFFERENTIATION
- Oncogenic Properties of Apoptotic Tumor Cells in Aggressive B Cell Lymphoma
- (2015) Catriona A. Ford et al. CURRENT BIOLOGY
- Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer
- (2015) Joseph Wahler et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Limited Mitochondrial Permeabilization Causes DNA Damage and Genomic Instability in the Absence of Cell Death
- (2015) Gabriel Ichim et al. MOLECULAR CELL
- Caspase-3 Promotes Genetic Instability and Carcinogenesis
- (2015) Xinjian Liu et al. MOLECULAR CELL
- Transcriptome Analysis of Wnt3a-Treated Triple-Negative Breast Cancer Cells
- (2015) Sylvie Maubant et al. PLoS One
- P-cadherin signals through the laminin receptor α6β4 integrin to induce stem cell and invasive properties in basal-like breast cancer cells
- (2015) André Filipe Vieira et al. Oncotarget
- Somatic mutation load of estrogen receptor-positive breast tumors predicts overall survival: an analysis of genome sequence data
- (2014) Svasti Haricharan et al. BREAST CANCER RESEARCH AND TREATMENT
- Lack of correlation of stem cell markers in breast cancer stem cells
- (2014) Y Liu et al. BRITISH JOURNAL OF CANCER
- The nuclear γ-H2AX apoptotic ring: implications for cancers and autoimmune diseases
- (2014) Stéphanie Solier et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Tumor-Associated Macrophages: From Mechanisms to Therapy
- (2014) Roy Noy et al. IMMUNITY
- The Soft Agar Colony Formation Assay
- (2014) Stanley Borowicz et al. Jove-Journal of Visualized Experiments
- p53 in breast cancer subtypes and new insights into response to chemotherapy
- (2013) Philippe Bertheau et al. BREAST
- The loss of the BH3-only Bcl-2 family member Bid delays T-cell leukemogenesis in Atm−/− mice
- (2013) S Biswas et al. CELL DEATH AND DIFFERENTIATION
- BH3 Mimetics: Status of the Field and New Developments
- (2013) C. Billard MOLECULAR CANCER THERAPEUTICS
- TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer
- (2013) Virginie Maire et al. PLoS One
- CXCR4 activation maintains a stem cell population in tamoxifen-resistant breast cancer cells through AhR signalling
- (2012) A Dubrovska et al. BRITISH JOURNAL OF CANCER
- Polo-like Kinase 1: A Potential Therapeutic Option in Combination with Conventional Chemotherapy for the Management of Patients with Triple-Negative Breast Cancer
- (2012) V. Maire et al. CANCER RESEARCH
- Cell survival, DNA damage, and oncogenic transformation after a transient and reversible apoptotic response
- (2012) Ho Lam Tang et al. MOLECULAR BIOLOGY OF THE CELL
- Molecular Characteristics and Metastasis Predictor Genes of Triple-Negative Breast Cancer: A Clinical Study of Triple-Negative Breast Carcinomas
- (2012) Wen-Hung Kuo et al. PLoS One
- Novel Mechanism of Anti-apoptotic Function of 78-kDa Glucose-regulated Protein (GRP78)
- (2011) Hui Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Caspase 3–mediated stimulation of tumor cell repopulation during cancer radiotherapy
- (2011) Qian Huang et al. NATURE MEDICINE
- BH3-only protein Bik is involved in both apoptosis induction and sensitivity to oxidative stress in multiple myeloma
- (2010) L Bodet et al. BRITISH JOURNAL OF CANCER
- p53-Mediated Hematopoietic Stem and Progenitor Cell Competition
- (2010) Tanya Bondar et al. Cell Stem Cell
- Apoptosis of leukocytes triggered by acute DNA damage promotes lymphoma formation
- (2010) V. Labi et al. GENES & DEVELOPMENT
- Apoptosis-promoted tumorigenesis: -irradiation-induced thymic lymphomagenesis requires Puma-driven leukocyte death
- (2010) E. M. Michalak et al. GENES & DEVELOPMENT
- Genomic Index of Sensitivity to Endocrine Therapy for Breast Cancer
- (2010) W. Fraser Symmans et al. JOURNAL OF CLINICAL ONCOLOGY
- TRAIL treatment provokes mutations in surviving cells
- (2010) M M Lovric et al. ONCOGENE
- PAR bZIP-bik is a novel transcriptional pathway that mediates oxidative stress-induced apoptosis in fibroblasts
- (2009) A Ritchie et al. CELL DEATH AND DIFFERENTIATION
- TGF-β induces apoptosis in human B cells by transcriptional regulation of BIK and BCL-XL
- (2009) L C Spender et al. CELL DEATH AND DIFFERENTIATION
- BIK, the founding member of the BH3-only family proteins: mechanisms of cell death and role in cancer and pathogenic processes
- (2009) G Chinnadurai et al. ONCOGENE
- Antiestrogen-resistant subclones of MCF-7 human breast cancer cells are derived from a common monoclonal drug-resistant progenitor
- (2009) K. R. Coser et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Growth of cancer cell lines under stem cell-like conditions has the potential to unveil therapeutic targets
- (2008) Germana Rappa et al. EXPERIMENTAL CELL RESEARCH
- The BH3-only protein Bik/Blk/Nbk inhibits nuclear translocation of activated ERK1/2 to mediate IFNγ-induced cell death
- (2008) Yohannes A. Mebratu et al. JOURNAL OF CELL BIOLOGY
- The endoplasmic reticulum (ER)-target protein Bik induces Hep3B cells apoptosis by the depletion of the ER Ca2+ stores
- (2008) Xiaoping Zhao et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Prognostic value of Bcl-2 in breast cancer patients treated with neoadjuvant anthracycline based chemotherapy
- (2008) Laura M. Vargas-Roig et al. Molecular Oncology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started